Anal cancer, primarily squamous cell carcinoma, remains under-addressed compared to other cancers, yet its incidence is increasing due to HPV prevalence, HIV co-infection, and demographic shifts. The market encompasses medications such as chemotherapeutics, immunotherapies, and targeted agents used alone or in combination with surgery/radiation. Key growth stems from greater awareness,...

"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...